Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients

BACKGROUND: The treatment of metastatic breast cancer (MBC) remains a great clinical challenge as drug resistance frequently develops. Alternative agents that can overcome drug resistance would offer new therapeutic options. The primary aim of this phase II study was to evaluate the efficacy and saf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Zhang, Pin, Tong, Zhongsheng, Tian, Fuguo, Wang, Yongsheng, Yang, Junlan, Li, Weilian, Di, Lijun, Liu, Wei, Tang, Li, Qiu, Rongguo, Xu, Binghe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982136/
https://ncbi.nlm.nih.gov/pubmed/27516093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0297-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados